Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Cancers
|
April 27, 2024
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors
S Lindsey Davis, Wells A Messersmith, W Thomas Purcell, et al.
Liver Cancer
|
May 14, 2026
A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma
Anthony B El-Khoueiry, Christopher H Lieu, Ghassan K Abou-Alfa, et al.
Plos One
|
April 10, 2024
Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL)
Hayley J Hawkins, Betelehem W Yacob, Monica E Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2017
Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer
Efrat Dotan, Steven J Cohen, Alexander N Starodub, et al.
JAMA Network Open
|
May 24, 2024
Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis
Joshua Demb, Jennifer M Kolb, Jonathan Dounel, et al.
Frontiers in Oncology
|
April 16, 2026
Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model
Robert W Lentz, Adrian T A Dominguez, Nicole Baranda Balmaceda, et al.
Molecular Cancer Therapeutics
|
January 30, 2016
Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer
Colin D Weekes, Laetitia E Lamberts, Mitesh J Borad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2020
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)
Scott Kopetz, Katherine A Guthrie, Van K Morris, et al.
Frontiers in Oncology
|
November 24, 2022
Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models
Julie Lang, Alexis D Leal, Juan A Marín-Jiménez, et al.
Cancer Research
|
July 26, 2018
Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer
Anuradha Krishnamurthy, Arvind Dasari, Anne M Noonan, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Cancers
|
April 27, 2024
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors
S Lindsey Davis, Wells A Messersmith, W Thomas Purcell, et al.
Liver Cancer
|
May 14, 2026
A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma
Anthony B El-Khoueiry, Christopher H Lieu, Ghassan K Abou-Alfa, et al.
Plos One
|
April 10, 2024
Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL)
Hayley J Hawkins, Betelehem W Yacob, Monica E Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2017
Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer
Efrat Dotan, Steven J Cohen, Alexander N Starodub, et al.
JAMA Network Open
|
May 24, 2024
Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis
Joshua Demb, Jennifer M Kolb, Jonathan Dounel, et al.
Frontiers in Oncology
|
April 16, 2026
Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model
Robert W Lentz, Adrian T A Dominguez, Nicole Baranda Balmaceda, et al.
Molecular Cancer Therapeutics
|
January 30, 2016
Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer
Colin D Weekes, Laetitia E Lamberts, Mitesh J Borad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 28, 2020
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)
Scott Kopetz, Katherine A Guthrie, Van K Morris, et al.
Frontiers in Oncology
|
November 24, 2022
Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models
Julie Lang, Alexis D Leal, Juan A Marín-Jiménez, et al.
Cancer Research
|
July 26, 2018
Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer
Anuradha Krishnamurthy, Arvind Dasari, Anne M Noonan, et al.
Page
of 7